Skip to main content
HK inno.N Corporation logo

HK inno.N Corporation — Investor Relations & Filings

Ticker · 195940 ISIN · KR7195940002 KO Manufacturing
Open in API
Filings indexed 256 across all filing types
Latest filing 2024-10-30 Report Publication Anno…
Country KR South Korea
Listing KO 195940

About HK inno.N Corporation

https://www.inno-n.com/eng

HK inno.N Corporation is a biohealth company engaged in the development, manufacturing, and distribution of pharmaceutical and consumer healthcare products. The company operates through two main divisions: Specialty Medicines and Health & Beauty (H&B). The Specialty Medicines division focuses on prescription drugs, with research and development centered on novel treatments for gastrointestinal diseases, immune diseases, and cancer. Its bio-research efforts also include vaccines and next-generation cell and gene therapies. The Health & Beauty division provides consumer products such as health functional foods and beauty items, supported by dedicated research into new materials and ingredients. The company leverages its integrated R&D capabilities to offer innovative solutions across both its pharmaceutical and consumer health markets.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (815 characters) notifying the market of an upcoming Investor Relations (IR) event, specifically a conference call to discuss 2024 Q3 financial results. It provides the date, time, location, and purpose of the meeting. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation deck or the full financial report itself, it is classified as a Report Publication Announcement (RPA).
2024-10-30 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting (NDR/one-on-one meetings) for HK inno.N. It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) or a general announcement.
2024-10-30 Korean
투자설명서
Capital/Financing Update Classification · 100% confidence The document is a '투자설명서' (Investment Prospectus) issued by HK inno.N Corp regarding the issuance of corporate bonds (5-1 and 5-2 series). It details the offering amount, interest rates, maturity dates, use of proceeds, and risk factors associated with the investment. In the context of financial filings, a prospectus for debt issuance falls under capital raising and financing activities.
2024-10-24 Korean
증권발행실적보고서
Capital/Financing Update Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the issuance of corporate bonds (무보증일반사채), including the total amount, interest rates, maturity dates, and the use of proceeds (debt repayment). This document type is a standard regulatory filing related to capital raising and financing activities. Since it specifically reports the results of a securities issuance (debt), it falls under the 'Capital/Financing Update' category.
2024-10-24 Korean
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short notice (536 characters) titled '결산실적공시 예고' (Notice of Earnings Release). It informs shareholders of the upcoming date (2024-10-30) for the release of the 2024 Q3 financial results. Since it is an announcement regarding the timing of a future report rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2024-10-23 Korean
[발행조건확정]증권신고서(채무증권)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) specifically for debt securities (채무증권). It details the finalization of issuance terms (interest rates) for corporate bonds. This falls under capital raising and financing activities. Since it is a formal regulatory filing regarding the terms of a debt issuance, it is classified as a Capital/Financing Update.
2024-10-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.